Sotaterceptsotatercept-associatedpulmonary arterial hypertensionFDA
…Purpose Sotatercept, an activin signalling inhibitor approved in March 2024 for pul…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: sotatercept-associated ×
sotatercept-associated
This drug is selected. Its supporting articles are shown below.